The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
Abstract
Purpose To describe the effect of atrial fibrillation on long-term morbidity and mortality.Subjects and methods The Renfrew/Paisley Study surveyed 7052 men and 8354 women aged 45-64 years between 1972 and 1976. All hospitalizations and deaths occurring during the subsequent 20 years were analyzed by the presence or absence of atrial fibrillation at baseline. Lone atrial fibrillation was defined in the absence of other cardiovascular signs or symptoms. Cox proportional hazards models were used to adjust for age and cardiovascular conditions.Results After 20 years, 42 (89%) of the 47 women with atrial fibrillation had a cardiovascular event (death or hospitalization), compared with 2276 (27%) of the 8307 women without this arrhythmia. Among men, 35 (66%) of 53 with atrial fibrillation had an event, compared with 3151 (45%) of 6999 without atrial fibrillation. In women, atrial fibrillation was an independent predictor of cardiovascular events (rate ratio [RR] = 3.0; 95% confidence interval [CI]: 2.1-4.2), fatal or nonfatal strokes (RR = 3.2; 95% CI: 1.0-5.0), and heart failure (RR = 3.4; 95% CI: 1.9-6.2). The rate ratios among men were 1.8 (95% CI: 1.3-2.5) for cardiovascular events, 2.5 (95% CI: 1.3-4.8) for strokes, and 3.4 (95% CI: 1.7-6.8) for heart failure. Atrial fibrillation was an independent predictor of all-cause mortality in women (RR = 2.2; 95% CI: 1.5-3.2) and men (RR = 1.5; 95% CI: 1.2-2.2). However, lone atrial fibrillation (which occurred in 15 subjects) was not associated with a statistically significant increase in either cardiovascular events (RR = 1.5; 95% CI: 0.6-3.6) or mortality (RR = 1.8; 95% CI: 0.9-3.8).Conclusions Atrial fibrillation is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality, especially in women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a rabbit model, left atrial and pulmonary vein tissue from females displayed longer action potential duration, and female pulmonary vein tissue had a more negative resting membrane potential compared with males.147”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [147]
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Epidemiologic Features of Chronic Atrial Fibrillation
Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204293061703 · Cited by 2,304
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033
Petersen, P., GODTFREDSEN, J., Boysen, G., Andersen, E. D., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,814
Lüderitz, B. (1999) · Journal of interventional cardiac electrophysiology · doi:10.1023/a:1009863214233 · Cited by 1,709
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,636
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators* (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,525
Krahn, A. D., Manfreda, J., TATE, R. B., Mathewson, F. A. L., & Cuddy, T. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80348-9 · Cited by 1,478
The diagnosis of ischaemic heart pain and intermittent claudication in field surveys.
Rose, G. A. (1962) · Europe PMC (PubMed Central) · Cited by 1,328
More ‘Malignant’ Than Cancer? Five-Year Survival Following a First Admission for Heart Failure
Stewart, S., Macintyre, K., Hole, D. J., Capewell, S., & McMurray, J. J. V. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00141-0 · Cited by 1,064
Self-citationLipowski, Z. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92478-7 · Cited by 951
Hole, D. J., Watt, G. C. M., Davey-Smith, G., Hart, C., Gillis, C. R., & Hawthorne, V. M. (1996) · BMJ · doi:10.1136/bmj.313.7059.711 · Cited by 910
Self-citationTachycardia-Induced Cardiomyopathy: A Review of Animal Models and Clinical Studies
Shinbane, J. S., Wood, M. A., Jensen, D. N., Ellenbogen, K. A., Fitzpatrick, A. P., & Scheinman, M. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00592-x · Cited by 800
Epidemiology and natural history of atrial fibrillation: clinical implications
Chugh, S. S., Blackshear, J. L., Shen, W.-K., Hammill, S. C., & Gersh, B. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01107-4 · Cited by 768
Prineas, R. J., Crow, R. S., & BLACKBURN, H. W. (1982) · Cited by 701
Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs
Wolf, P. A., Mitchell, J. B., Baker, C. S., Kannel, W. B., & D’Agostino, R. B. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.3.229 · Cited by 683
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2001) · Heart · doi:10.1136/heart.86.5.516 · Cited by 661
Self-citationSurvival of patients with a new diagnosis of heart failure: a population based study
Cowie, M., Wood, D. A., Coats, A. J. S., Thompson, S. G., Suresh, V., Poole-Wilson, P. A., & Sutton, G. C. (2000) · Heart · doi:10.1136/heart.83.5.505 · Cited by 575
Secular trends in the prevalence of atrial fibrillation: The Framingham study
Wolf, P. A., Benhamin, E. J., Belanger, A. J., Kannel, W. B., Levy, D., & D'Agostino, R. B. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90288-4 · Cited by 446
The Scottish Record Linkage System.
Kendrick, S. W., & Clarke, J. (1993) · PubMed · Cited by 377
Minnesota Code Manual of Electrocardiographic Findings
Marty, A. T. (1983) · Critical Care Medicine · doi:10.1097/00003246-198307000-00029 · Cited by 311
Tachycardia-induced cardiomyopathy
Umaña, E., Solares, C. A., & Alpert, M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01472-9 · Cited by 274
Redfield, M. M., Kay, G. N., Jenkins, L. S., Mianulli, M. J., Jensen, D. N., & Ellenbogen, K. A. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.8.790 · Cited by 202
Evidence of inadequate investigation and treatment of patients with heart failure.
Clarke, K., Gray, D. P., & Hampton, J. R. (1994) · Heart · doi:10.1136/hrt.71.6.584 · Cited by 194
Stewart, S. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2511 · Cited by 163
Self-citationAtrial Fibrillation in Heart Failure
Stevenson, W. G., & Stevenson, L. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411209 · Cited by 141
Hawthorne, V. M., Watt, G. C. M., Hart, C., Hole, D. J., Smith, G. D., & Gillis, C. R. (1995) · Scottish Medical Journal · doi:10.1177/003693309504000402 · Cited by 113
Self-citationQuality of Scottish Morbidity Record (SMR) data.
Harley, K., & Jones, C. (1996) · PubMed · Cited by 109
Murdoch, D., Love, M. P., Robb, S. D., McDonagh, T. A., Davie, A. P., Ford, I., Capewell, S., Morrison, C., & McMurray, J. J. V. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1269 · Cited by 98
Self-citationThe Natural History of Atrial Fibrillation:
WIJFFELS, M. C. E. F. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00297.x · Cited by 67
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
Hart, R. G., & Pearce, L. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-10-200005160-00017 · Cited by 49
Research works printed but not linked: 2
- 1965, Definition and classification of chronic bronchitis for epidemiological purposes, Lancet, i, 775
- Clarke, 1994, Evidence of inadequate investigation and treatment of patients with heart failure, Br Heart J, 71, 584, 10.1136/hrt.71.6.584 · DOI
Cited by
Sorted by citations
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citationGuidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
Self-citation
Metadata
- Authors
- Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V.
- Affiliations
- University of South Australia (AU)
- University of Glasgow (GB)
- Corresponding author
- McMurray, John J.V
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2002-10
- Volume
- 113
- Issue
- 5
- Pages
- 359-364
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1971505725
- Cited by
- 1,562
- References
- 33
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 67 · 2023: 45 · 2022: 64 · 2021: 94 · 2020: 129 · 2019: 88 · 2018: 92 · 2017: 81 · 2016: 100 · 2015: 107 · 2014: 97 · 2013: 85 · 2012: 83
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- atrial fibrillation, long-term morbidity, cardiovascular mortality, stroke, heart failure, sex differences, lone atrial fibrillation, middle-aged adults, cardiovascular hospitalization, all-cause mortality, cardiovascular risk factors, atrial fibrillation risk factors, atrial fibrillation treatment, atrial fibrillation prevention, atrial fibrillation screening
- MeSH terms
- Atrial Fibrillation, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Scotland, Time Factors, Cohort Studies, Survival Rate, Proportional Hazards Models, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review